SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
5.16
-0.07 (-1.34%)
Sep 1, 2026, 3:05 PM EDT - Market open
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of $51.34 million as of September 1, 2026. Its market cap has increased by 47.29% in one year.
Market Cap
51.34M
Enterprise Value
-798.02K
1-Year Change
47.29%
Ranking
Category
Stock Price
$5.16
ChartMarket Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has decreased from $76.07M to $51.34M, a decrease of -32.51%. That is a compound annual growth rate of -3.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 51.34M | 93.45% |
| Dec 31, 2025 | 26.54M | -42.20% |
| Dec 31, 2024 | 45.92M | -44.66% |
| Dec 29, 2023 | 82.97M | 62.87% |
| Dec 30, 2022 | 50.94M | -70.72% |
| Dec 31, 2021 | 173.97M | 17.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BGM Group | 108.93M |
| Cumberland Pharmaceuticals | 100.24M |
| Zhengye Biotechnology Holding | 81.99M |
| Citius Oncology | 80.72M |
| InterCure | 70.94M |
| Talphera | 61.77M |
| Incannex Healthcare | 40.08M |
| China Pharma Holdings | 38.10M |